The BIOPRES-trial; Transrectal Biopsies of the Prostate: End versus Side firing

Recruiting

• Conditions: malignancy of the prostate; prostate cancer; 10038588

• Registration Number: NL-OMON32971
• Lead Sponsor: Amphia Ziekenhuis

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 6 May 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: Not specified
• Target Recruitment: 800

Inclusion Criteria

• All prostate biopsies
• PSA and DRE performed in advance of the biopsy
• Informed consent

Exclusion Criteria

none

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>The primary endpoint is the prostate cancer detection rate</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>secondary endpoints are the number of cores invaded with prostate cancer,<br /><br>nomogram for indolent cancer-score, Gleason score, complications and biopsy<br /><br>length</p><br>